59 related articles for article (PubMed ID: 11717590)
1. The role of immune activation in endotoxin-induced atherogenesis.
Wiedermann CJ; Kiechl S; Schratzberger P; Dunzendorfer S; Weiss G; Willeit J
J Endotoxin Res; 2001; 7(4):322-6. PubMed ID: 11717590
[TBL] [Abstract][Full Text] [Related]
2. Association of endotoxemia with carotid atherosclerosis and cardiovascular disease: prospective results from the Bruneck Study.
Wiedermann CJ; Kiechl S; Dunzendorfer S; Schratzberger P; Egger G; Oberhollenzer F; Willeit J
J Am Coll Cardiol; 1999 Dec; 34(7):1975-81. PubMed ID: 10588212
[TBL] [Abstract][Full Text] [Related]
3. Progression of carotid intima-media thickness and plasma antioxidants: the Los Angeles Atherosclerosis Study.
Dwyer JH; Paul-Labrador MJ; Fan J; Shircore AM; Merz CN; Dwyer KM
Arterioscler Thromb Vasc Biol; 2004 Feb; 24(2):313-9. PubMed ID: 14656738
[TBL] [Abstract][Full Text] [Related]
4. Oxidized phospholipids predict the presence and progression of carotid and femoral atherosclerosis and symptomatic cardiovascular disease: five-year prospective results from the Bruneck study.
Tsimikas S; Kiechl S; Willeit J; Mayr M; Miller ER; Kronenberg F; Xu Q; Bergmark C; Weger S; Oberhollenzer F; Witztum JL
J Am Coll Cardiol; 2006 Jun; 47(11):2219-28. PubMed ID: 16750687
[TBL] [Abstract][Full Text] [Related]
5. Is endotoxemia a risk factor for atherosclerosis?
Wiedermann CJ; Kiechl S; Willeit J
Wien Klin Wochenschr; 2001 Feb; 113(3-4):77-9. PubMed ID: 11253743
[No Abstract] [Full Text] [Related]
6. Potential role of endotoxin as a proinflammatory mediator of atherosclerosis.
Stoll LL; Denning GM; Weintraub NL
Arterioscler Thromb Vasc Biol; 2004 Dec; 24(12):2227-36. PubMed ID: 15472123
[TBL] [Abstract][Full Text] [Related]
7. Soluble receptor activator of nuclear factor-kappa B ligand and risk for cardiovascular disease.
Kiechl S; Schett G; Schwaiger J; Seppi K; Eder P; Egger G; Santer P; Mayr A; Xu Q; Willeit J
Circulation; 2007 Jul; 116(4):385-91. PubMed ID: 17620507
[TBL] [Abstract][Full Text] [Related]
8. Low-grade endotoxemia in patients with severe autism.
Emanuele E; Orsi P; Boso M; Broglia D; Brondino N; Barale F; di Nemi SU; Politi P
Neurosci Lett; 2010 Mar; 471(3):162-5. PubMed ID: 20097267
[TBL] [Abstract][Full Text] [Related]
9. Immune activation as effect modifier of atherogenesis in chronic infection.
Ricevuti G; Gritti D; Gasparetto C; Wiedermann CJ
Int Rev Immunol; 2002; 21(1):27-31. PubMed ID: 12187843
[TBL] [Abstract][Full Text] [Related]
10. Serum neopterin, an immune activation marker, independently predicts disease progression in advanced HIV-1 infection.
Mildvan D; Spritzler J; Grossberg SE; Fahey JL; Johnston DM; Schock BR; Kagan J
Clin Infect Dis; 2005 Mar; 40(6):853-8. PubMed ID: 15736019
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-6 infusion during human endotoxaemia inhibits in vitro release of the urokinase receptor from peripheral blood mononuclear cells.
Ostrowski SR; Plomgaard P; Fischer CP; Steensberg AS; Møller K; Høyer-Hansen G; Pedersen BK; Ullum H
Scand J Immunol; 2005 Feb; 61(2):197-206. PubMed ID: 15683457
[TBL] [Abstract][Full Text] [Related]
12. Circulating soluble CD44 is higher among women than men and is not associated with cardiovascular risk factors or subclinical atherosclerosis.
Sjöberg S; Fogelstrand L; Hulthe J; Fagerberg B; Krettek A
Metabolism; 2005 Feb; 54(2):139-41. PubMed ID: 15690305
[TBL] [Abstract][Full Text] [Related]
13. Comparison of risk factors for vascular disease in the carotid artery and aorta in women with systemic lupus erythematosus.
Selzer F; Sutton-Tyrrell K; Fitzgerald SG; Pratt JE; Tracy RP; Kuller LH; Manzi S
Arthritis Rheum; 2004 Jan; 50(1):151-9. PubMed ID: 14730611
[TBL] [Abstract][Full Text] [Related]
14. C-reactive protein, interleukin-6, and soluble adhesion molecules as predictors of progressive peripheral atherosclerosis in the general population: Edinburgh Artery Study.
Tzoulaki I; Murray GD; Lee AJ; Rumley A; Lowe GD; Fowkes FG
Circulation; 2005 Aug; 112(7):976-83. PubMed ID: 16087797
[TBL] [Abstract][Full Text] [Related]
15. Type 2 diabetes in patients with end-stage renal disease is not associated with further increased serum inflammatory parameters.
Bodlaj G; Berg J; Pichler R; Sailer T; Biesenbach G
J Nephrol; 2004; 17(1):112-7. PubMed ID: 15151267
[TBL] [Abstract][Full Text] [Related]
16. Oxidized low-density lipoprotein autoantibodies, chronic infections, and carotid atherosclerosis in a population-based study.
Mayr M; Kiechl S; Tsimikas S; Miller E; Sheldon J; Willeit J; Witztum JL; Xu Q
J Am Coll Cardiol; 2006 Jun; 47(12):2436-43. PubMed ID: 16781371
[TBL] [Abstract][Full Text] [Related]
17. Oxidized phospholipids, lipoprotein(a), lipoprotein-associated phospholipase A2 activity, and 10-year cardiovascular outcomes: prospective results from the Bruneck study.
Kiechl S; Willeit J; Mayr M; Viehweider B; Oberhollenzer M; Kronenberg F; Wiedermann CJ; Oberthaler S; Xu Q; Witztum JL; Tsimikas S
Arterioscler Thromb Vasc Biol; 2007 Aug; 27(8):1788-95. PubMed ID: 17541022
[TBL] [Abstract][Full Text] [Related]
18. Risk of atherosclerosis: interaction of smoking and glutathione S-transferase genes.
Olshan AF; Li R; Pankow JS; Bray M; Tyroler HA; Chambless LE; Boerwinkle E; Pittman GS; Bell DA
Epidemiology; 2003 May; 14(3):321-7. PubMed ID: 12859033
[TBL] [Abstract][Full Text] [Related]
19. Hemostatic factors, inflammatory markers, and progressive peripheral atherosclerosis: the Edinburgh Artery Study.
Tzoulaki I; Murray GD; Price JF; Smith FB; Lee AJ; Rumley A; Lowe GD; Fowkes FG
Am J Epidemiol; 2006 Feb; 163(4):334-41. PubMed ID: 16357107
[TBL] [Abstract][Full Text] [Related]
20. Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. pylori specific DNA in human coronary atherosclerotic plaque.
Kowalski M
J Physiol Pharmacol; 2001 Aug; 52(1 Suppl 1):3-31. PubMed ID: 11795863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
